Combined Respiratory Training for ALS
Trial Summary
What is the purpose of this trial?
The goal of this interventional trial is to learn about lung volume recruitment (LVR) and expiratory muscle strength training (EMST) in a total of up to 39 patients diagnosed with ALS. The following aims will be addressed: 1. Determine the impact of combined LVR and EMST on cough strength and respiratory function in individuals with ALS. 2. Determine the impact of combined LVR and EMST on patient-reported dyspnea and bulbar impairment. 3. Describe the effect of combined LVR and EMST on patient- and caregiver reported burden and quality of life.
Will I have to stop taking my current medications?
The trial information does not specify if you need to stop taking your current medications. However, if you are using prescription cough assist or non-invasive volume ventilation devices, you cannot participate in the trial.
What data supports the effectiveness of the treatment Combined Respiratory Training for ALS?
Is Combined Respiratory Training safe for humans?
How does the Combined Respiratory Training treatment for ALS differ from other treatments?
Combined Respiratory Training for ALS is unique because it combines Lung Volume Recruitment (a technique to improve lung capacity and coughing) and Expiratory Muscle Strength Training (a method to enhance breathing muscle strength), which together aim to improve respiratory function and cough effectiveness in ALS patients, unlike standard treatments that may not address these specific aspects.137910
Research Team
Magalie Thomas, MBA
Principal Investigator
Nova Southeastern University
Eligibility Criteria
This trial is for people with ALS who have had symptoms for less than 2 years, can't already use respiratory training devices, and don't have a tracheostomy or need invasive breathing support. They shouldn't be in other studies that affect coughing or breathing and must not have severe lung diseases like COPD.Inclusion Criteria
Exclusion Criteria
Timeline
Screening/Baseline 1
Participants are screened for eligibility to participate in the trial
Baseline 2
Introduction of LVR and EMST training with initial training session
Active Training
Weekly telehealth therapy sessions including LVR and EMST training, peak cough flow assessment, and patient-reported outcomes
Final Evaluation
Final assessment procedures identical to Baseline 2
Follow-up
Monthly telehealth visits for peak cough flow and maximum phonation time assessments, and clinician-administered surveys
Treatment Details
Interventions
- Combined Respiratory Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
Nova Southeastern University
Lead Sponsor
Congressionally Directed Medical Research Programs
Collaborator